Skip to main content
. 2023 May 11;25(6):331–342. doi: 10.1007/s11883-023-01096-0

Table 2.

Summary of findings of the systematic review focused on the effectiveness of MNT provided by RDN for dyslipidemia

graphic file with name 11883_2023_1096_Tab2_HTML.jpg

A1c, glycosylated hemoglobin; BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; RCTs, randomized controlled trials; SBP, systolic blood pressure; TG, triglyceride; Total-C, total cholesterol

*Certainty of evidence information was reported as stated in the included systematic reviews. These systematic reviews used GRADE method to determine certainty of evidence for outcomes of interest and graded them as high, moderate, or low

Green shading indicates significant between group effect

Blue shading indicates non-significant between group effect